STERIS plc $STE Shares Acquired by Pitcairn Co.

Pitcairn Co. increased its position in shares of STERIS plc (NYSE:STE) by 129.3% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,745 shares of the medical equipment provider’s stock after purchasing an additional 2,112 shares during the period. Pitcairn Co.’s holdings in STERIS were worth $900,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in STE. Geneos Wealth Management Inc. increased its position in shares of STERIS by 34.9% during the 2nd quarter. Geneos Wealth Management Inc. now owns 174 shares of the medical equipment provider’s stock valued at $42,000 after purchasing an additional 45 shares during the period. CYBER HORNET ETFs LLC bought a new position in STERIS during the second quarter valued at about $62,000. Winslow Asset Management Inc. grew its holdings in STERIS by 1.3% during the second quarter. Winslow Asset Management Inc. now owns 32,194 shares of the medical equipment provider’s stock worth $7,734,000 after acquiring an additional 424 shares during the period. Evergreen Capital Management LLC raised its position in STERIS by 11.8% in the second quarter. Evergreen Capital Management LLC now owns 1,005 shares of the medical equipment provider’s stock worth $241,000 after acquiring an additional 106 shares in the last quarter. Finally, Headlands Technologies LLC bought a new stake in STERIS in the second quarter worth about $321,000. 94.69% of the stock is owned by institutional investors.

Insider Activity at STERIS

In other STERIS news, VP Julia Madsen sold 5,008 shares of STERIS stock in a transaction on Friday, November 21st. The shares were sold at an average price of $262.00, for a total transaction of $1,312,096.00. Following the completion of the sale, the vice president owned 10,710 shares of the company’s stock, valued at $2,806,020. This trade represents a 31.86% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, VP Renato Tamaro sold 5,036 shares of the business’s stock in a transaction on Tuesday, November 18th. The shares were sold at an average price of $257.55, for a total transaction of $1,297,021.80. Following the transaction, the vice president owned 5,695 shares in the company, valued at approximately $1,466,747.25. This represents a 46.93% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold 25,203 shares of company stock worth $6,624,667 in the last quarter. 1.07% of the stock is owned by corporate insiders.

STERIS Stock Up 0.9%

NYSE:STE opened at $254.07 on Tuesday. The business’s fifty day moving average price is $251.52 and its 200 day moving average price is $243.89. The firm has a market capitalization of $24.94 billion, a price-to-earnings ratio of 36.50 and a beta of 1.01. The company has a current ratio of 2.37, a quick ratio of 1.63 and a debt-to-equity ratio of 0.27. STERIS plc has a 1-year low of $200.98 and a 1-year high of $268.60.

STERIS (NYSE:STE) last announced its quarterly earnings data on Wednesday, November 5th. The medical equipment provider reported $2.47 EPS for the quarter, topping analysts’ consensus estimates of $2.38 by $0.09. The firm had revenue of $1.46 billion during the quarter, compared to analyst estimates of $1.43 billion. STERIS had a return on equity of 14.43% and a net margin of 12.07%.During the same period last year, the company posted $2.14 EPS. STERIS has set its FY 2026 guidance at 10.150-10.30 EPS. On average, sell-side analysts forecast that STERIS plc will post 9.08 earnings per share for the current fiscal year.

STERIS Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, December 18th. Shareholders of record on Tuesday, November 18th will be paid a $0.63 dividend. This represents a $2.52 annualized dividend and a yield of 1.0%. The ex-dividend date is Tuesday, November 18th. STERIS’s dividend payout ratio is currently 36.21%.

Analyst Upgrades and Downgrades

STE has been the subject of several research reports. Weiss Ratings restated a “buy (b)” rating on shares of STERIS in a research report on Tuesday, October 14th. Wall Street Zen upgraded shares of STERIS from a “buy” rating to a “strong-buy” rating in a report on Sunday, September 14th. Seven investment analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $273.50.

STERIS Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.